Equities Analysts Set Expectations for McKesson Q3 Earnings

McKesson Corporation (NYSE:MCK) – Equities research analysts at Leerink Partnrs lowered their Q3 2026 earnings per share (EPS) estimates for shares of McKesson in a research note issued to investors on Thursday, November 6th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $9.19 per share for the quarter, down from their prior estimate of $10.11. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share.

Several other analysts have also issued reports on the stock. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday. Evercore ISI reaffirmed an “outperform” rating and issued a $1,000.00 price objective on shares of McKesson in a research report on Thursday. Wells Fargo & Company lifted their target price on shares of McKesson from $772.00 to $816.00 and gave the stock an “equal weight” rating in a research report on Wednesday, September 24th. Zacks Research raised McKesson from a “hold” rating to a “strong-buy” rating in a report on Monday, October 27th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on McKesson from $775.00 to $856.00 and gave the company a “buy” rating in a research report on Wednesday, September 24th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $880.15.

McKesson Trading Down 0.9%

NYSE MCK opened at $850.77 on Monday. The business has a fifty day simple moving average of $757.54 and a 200 day simple moving average of $724.48. McKesson has a 12 month low of $558.13 and a 12 month high of $867.63. The firm has a market capitalization of $105.82 billion, a P/E ratio of 33.92, a PEG ratio of 1.46 and a beta of 0.51.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, November 5th. The company reported $9.86 earnings per share for the quarter, beating analysts’ consensus estimates of $8.84 by $1.02. The company had revenue of $103.15 billion for the quarter, compared to analyst estimates of $103.80 billion. McKesson had a negative return on equity of 196.66% and a net margin of 0.84%.The company’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter last year, the company earned $7.07 earnings per share.

Institutional Investors Weigh In On McKesson

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MCK. Norges Bank bought a new position in McKesson in the 2nd quarter worth approximately $1,346,661,000. Alliancebernstein L.P. boosted its holdings in shares of McKesson by 150.4% in the second quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock worth $1,661,956,000 after acquiring an additional 1,362,386 shares during the period. Nuveen LLC bought a new position in shares of McKesson in the first quarter worth $475,235,000. Arrowstreet Capital Limited Partnership grew its position in shares of McKesson by 56.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after purchasing an additional 446,060 shares in the last quarter. Finally, Wellington Management Group LLP raised its stake in shares of McKesson by 4,559.6% during the 1st quarter. Wellington Management Group LLP now owns 427,703 shares of the company’s stock valued at $287,840,000 after purchasing an additional 418,524 shares during the period. 85.07% of the stock is currently owned by institutional investors.

Insider Activity

In other McKesson news, CEO Brian S. Tyler sold 11,930 shares of the business’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $705.63, for a total value of $8,418,165.90. Following the sale, the chief executive officer directly owned 4,012 shares in the company, valued at $2,830,987.56. The trade was a 74.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.08% of the stock is currently owned by insiders.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, December 1st. McKesson’s dividend payout ratio (DPR) is currently 10.21%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.